Reporte zur Charge EN4207

Symptomtext

Menstruation after menopause; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 58-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 12Apr2022 at 12:00 as dose 3 (booster), single (Lot number: EN4207) at the age of 58 years, in left arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162b2 (Dose Number: 1, Batch/Lot No: EN4207, Location of injection: Arm Left, Vaccine Administration Time: 12:00 PM), administration date: 20Mar2021, when the patient was 57-year-old, for Covid-19 immunization. The following information was reported: MENSTRUATION IRREGULAR (non-serious) with onset 30Apr2022 at 12:00, outcome "not recovered", described as "Menstruation after menopause". The event "menstruation after menopause" required physician office visit. Therapeutic measures were not taken as a result of menstruation irregular Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. No follow-up attempts are needed. No further information is expected.